ClinicalTrials.gg
Sign In

Common Cold clinical trials

The registry lists 219 studies for Common Cold across more than 10 countries. 23 are recruiting or about to start. 138 of them are mainly about Common Cold (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-02.

Get an email when these change. Save the Common Cold studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
161
Status unknown
17
Recruiting
14
Withdrawn
9
Not yet recruiting
8
Terminated
6

Phase

Phase 3
47
Phase 2
28
Phase 4
21
Phase 1
9
Early Phase 1
1

Where

United States
47
United Kingdom
20
Russian Federation
13
Brazil
12
Germany
11
Italy
10

Who runs them

GlaxoSmithKline (9) · Valenta Pharm JSC (9) · Ache Laboratorios Farmaceuticos S.A. (6) · Bayer (5) · Enzymatica AB (5) · EMS (4) · Novartis (3) · Acibadem University (3)

What is being tested here

Drugs under test in Common Cold studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Pentanedioic acid imidazolyl ethanamide146
Ornidazole101
Dipyrone111
Fish Oils101
Omalizumab101
Acetaminophen048
Aspirin035
Echinacea extract024
Pseudoephedrine034
Phenylephrine034

Drug classes tested here NSAIDs 6 · Antihistamines 4

Coming up

2phase 3 studies under way
15studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 14 Common Cold studies recruiting now, 4 (29%) set no upper age limit and 9 (64%) stop at 75 or younger. 4 (29%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 7 (50%) take healthy volunteers.

Recruiting studies that take each age, of 14
AgeWomenMen
101 (7%)1 (7%)
1811 (79%)11 (79%)
3011 (79%)11 (79%)
4011 (79%)11 (79%)
509 (64%)9 (64%)
659 (64%)9 (64%)
755 (36%)5 (36%)
854 (29%)4 (29%)

Across all 219 studies, recruiting or not: 64% stop at 75 or younger and 53% at 65; 28% take children; 1% are for women only and 3% for men only; 44% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Common Cold studies take

Of 17 phase 3 interventional studies under Common Cold, half reached primary completion within 7 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 37 mo5–16 · 17 studies——
Interventional, no phase10 mo3–16 · 49 studies——
Observational20 mo2–35 · 12 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered1

Studies

Recruiting first, then most recently updated. Showing 50 of 219. Browse all 219 → or search them.